Search
for

    Sort by

    Research 61–90 of 1000+

    1. Chemotherapy and the Skin: Understanding Dermatologic Side Effects Cureus · 2026
    2. Mirtazapine-induced Gynecomastia: An Unknown Side Effect? Journal of Psychiatry Spectrum · 2025
    3. HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE? Psychiatria Danubina · 2021
    4. Dermatological manifestations of COVID-19 and its therapies: a review International Journal of Research in Dermatology · 2021
    5. DERMATOLOJİK ACİLLER 2014
    6. Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health Zenodo (CERN European Organization for Nuclear Research) · 2025
    7. Atypical post-finasteride syndrome: A pharmacological riddle Indian Journal of Pharmacology · 2016 · 8 citations
    8. Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases International Journal of Impotence Research · 2022 · 2 citations
    9. Cutaneous drug reactions Elsevier eBooks · 2010 · 1 citations
    10. Adverse Reactions to Enemas JAMA · 1976
    11. Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors: A Clinical Review of Reaction Patterns Dermatology Practical & Conceptual · 2026
    12. Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms Eurasian Journal of Medicine · 2026
    13. Severe cutaneous adverse reactions to drugs The Lancet · 2017 · 273 citations
    14. Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database BioDrugs · 2024 · 1 citations
    15. Harmless Herbs? A Review of the Recent Literature The American Journal of Medicine · 1998 · 581 citations
    16. Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health Zenodo (CERN European Organization for Nuclear Research) · 2025
    17. Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health Zenodo (CERN European Organization for Nuclear Research) · 2025
    18. Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer Journal of Clinical Oncology · 2008 · 35 citations
    19. Hyperammonemia with Valproic Acid: Colonic Ischemia Associated with “Triptan” Use Visual Side Effects with Pegylated Interferon: Alopecia Areata with Infliximab: Adverse Effects Seen with Medications Used for Irritable Bowel Syndrome Hospital pharmacy · 2004 · 2 citations
    20. Acute Encephalomyelitis Syndromes Associated with H1N1 Influenza Vaccinations; Erythema Multiforme Secondary to H1N1 Vaccine; Cytolytic Hepatitis Possibly Related to Oral Contraceptives; Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Associated with Lamotrigine: First Report; Behavioral Disinhibition with Baclofen; Minoxidil-Induced Trichostasis Spinulosa of Terminal Hair; Delayed-Onset Mirtazapine-Related Leukopenia Hospital Pharmacy · 2011 · 1 citations
    21. Cerebral Ischemia Related to Isotretinoin; Venlafaxine-Induced Alopecia; Cognitive Dysfunction with Tolterodine; Retinal Artery Occlusion after Injection of Long-Acting Risperidone; Olanzapine-Induced Chylomicronemia Presenting as Pancreatitis; Metabolic Effects of the Atypical Antipsychotics – an Editorial; Another Drug-Induced Pancreatitis – This One Caused by a Tyrosine Kinase Inhibitor; Suicide Attempts Related to Antidepressant Medications Hospital pharmacy · 2007
    22. Psychoactive drugs and skin Journal of the European Academy of Dermatology and Venereology · 2003 · 12 citations
    23. Drug eruptions in dermatology Expert Review of Dermatology · 2011 · 11 citations
    24. Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network Oncotarget · 2017 · 18 citations
    25. The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database MedBA Medicine · 2026
    26. Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent? Cutis · 2023 · 1 citations
    27. Alopecia Universalis: an extremely rare but probable adverse effect of adalimumab IOSR journal of pharmacy · 2014
    28. Reporting on Adverse Clinical Events Clin-Alert · 2015
    29. Psoriatic Alopecia/Alopecia Areata‐Like Reactions Secondary to Anti‐Tumour Necrosis Factor‐Alpha Therapy Australasian Journal of Dermatology · 2025 · 1 citations
    30. Impact of Chemotherapeutic Drug on People living with Cancer International Research Journal of Modernization in Engineering Technology and Science · 2024